Summary
Seroepidemiological and molecular biological studies have established an association of Hodgkin’s disease with Epstein-Barr virus. Recently, Epstein-Barr virus genomes and gene products have been detected in the neoplastic cells of approximately 50% of cases, most notably the latent membrane protein, which has transforming potential. However, Epstein-Barr virus was not restricted to neoplastic cells. In situ hybridization, employing probes for the small Epstein-Barr virus-encoded nuclear RNAs EBER 1 and −2, helped to precisely characterize phenotype and distribution of all latently Epstein-Barr virus-infected cells, indicating the presence of usually small numbers of Epstein-Barr virus-infected, but latent membrane protein-negative, non-malignant B-cells of polyclonal origin in lymph nodes from Hodgkin’s disease patients and normal controls. In contrast, the neoplastic cells and the Epstein-Barr virus genomes expressing latent membrane protein in these cells appear to be monoclonal in nature, which points to specific immunological deficiencies in Hodgkin’s disease patients and suggests that Epstein-Barr virus may contribute to the etiology of a significant proportion of Hodgkin’s disease cases.
Similar content being viewed by others
References
Anagnostopoulos I, Herbst H, Niedobitek G, Stein H, Demonstration of monoclonal EBV genomes in Hodgkin’s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern and in situ hybridization. Blood 74:810, 1989
Brousset P, Chittal S, Schlaifer D, Icart J, Payen C, Rigal-Huguet F, Voigt JJ, Delsol G, Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin’s disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) section. Blood 77: 1781, 1991
Delsol G, Brousset P, Chittal S, Rigal-Huguet F, Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylatedBamHI-W probes in Hodgkin’s disease. Am J Pathol 140: 247, 1992
Diehl V, Kalle C von, Fonatsch C, Tesch H, Jücker M, Schaadt M, The cell of origin in Hodgkin’s disease. Semin Oncol 17: 660, 1990
Gledhill S, Gallagher A, Jones DB, Krajewski AS, Alexander FE, Klee E, Wright DH, O’Brien C, Onions DE, Jarrett RF, Viral involvement in Hodgkin’s disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 64: 227, 1991
Gutensohn NM, Cole P, Epidemiology of Hodgkin’s disease. Semin Oncol 7: 92, 1980
Henderson S, Rowe M, Croom-Carter D, Wang F, Longnecker L, Kieff E, Rickinson A, Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107, 1991
Herbst H, Tippelmann G, Anagnostopoulos I, Gerdes J, Schwarting R, Boehm T, Pileri S, Jones DB, Stein H, Immunoglobulin and T cell receptor gene rearrangements in Hodgkin’s disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between genotype and phenotype. Leuk Res 13: 103, 1989
Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H, High incidence of Epstein-Barr virus genomes in Hodgkin’s disease. Am J Pathol 137: 13, 1990
Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch N, Stein H, Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells, Proc Natl Acad Sci USA 88: 4766, 1991
Herbst H, Dallenbach F, Hummel M, Niedobitek G, Rowe M, Young LS, Müller-Lantzsch N, Stein H, Epstein-Barr virus DNA and latent gene products in CD30-positive anaplastic large cell lymphomas. Blood 78: 2666, 1991
Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H, Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin’s disease. Blood 80: 484, 1992
Herbst H, Niedobitek G, Stein H, Epstein-Barr virus and CD30-positive malignant lymphomas. CRC Crit Rev Oncogenesis (in press)
Knecht H, Odermatt BF, Bachmann E, Teixeira S, Sahli R, Hayoz D, Heitz P, Bachmann F, Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin’s disease without genomic evidence of B- or T-cell clonality. Blood 78: 760, 1991
Lukes RJ, Butler JJ, The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26: 1063, 1966
Masih A, Weisenburger D, Duggan M, Armitage J, Bashir R, Mitchell D, Wickert R, Purtillo DT, Epstein-Barr viral genome in lymph nodes from patients with Hodgkin’s disease may be not specific to Reed-Sternberg cells. Am J Pathol 139: 37, 1991
Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk F, Vogelman J, Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320: 689, 1989
Niedobitek G, Herbst H, Epstein-Barr virus and carcinomas. Int J Clin Lab Res (in press)
Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H, Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79: 2520, 1992
Nonoyama M, Kawai Y, Huang CH, Pagano JS, Hirshaut Y, Levine PH, Epstein-Barr virus DNA in Hodgkin’s disease, American Burkitt’s lymphoma, and other human tumors. Cancer Res 34: 1228, 1974
Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS, Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin’s disease. Lancet 337: 320, 1991
Pallesen G, Sandvej K, Hamilton-Dutoit SJ Rowe M, Young LS, Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 78: 1162 1991
Poppema S, Imhoff G van, Torensma R, Smit J, Lymphadenopathy morphologically consistent with Hodgkin’s disease associated with Epstein-Barr virus infection. Am J Clin Pathol 84: 385, 1985
Said JW, Sassoon AF, Shintaku IP, Kurtin PJ, Pinkus GS, Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin’s disease Results of Southern blot and polymerase chain reaction. Am J Pathol 138: 261, 1991
Staal, SP, Ambinder R, Beschorner WE, Hayward G, Mann R, A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin’s disease. Am J Clin Pathol 91: 1, 1989
Stein H, Mason DY, Gerdes J, O’Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K, The expression of Hodgkin’s disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66: 849, 1985
Stetler-Stevenson M, Crush-Stanton S, Cossman J, Involvement of thebcl-2 gene in Hodgkin’s disease. J Natl Cancer Inst 82: 855, 1990
Uccini S, Monardo F, Stoppaccioro A, Gradilone A, Agliano AM, Maggioni A, Manzari V, Vago L, Costanzi G, Ruco LP, Baroni C, High frequency of Epstein-Barr virus genome detection in Hodgkin’s disease of HIV-positive patients. Int J Cancer 46: 581, 1990
Vestlev PM, Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Bendtzen SM, Prognosis of Hodgkin’s disease is not influenced by Epstein-Barr virus latent membrane antigen. Int J Cancer 50: 670, 1992
Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J, Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol 129: 86, 1987
Weiss LM, Movahed AM, Warnke RA, Sklar J, Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320: 502, 1989
Weiss LM, Chen YY, Liu XF, Shibata D, Epstein-Barr virus and Hodgkin’s disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139: 1259, 1991
Wright CF, Reid AH, Tsai MM, Ventre KM, Murari PJ, Frizzera G, O’Leary TJ, Detection of Epstein-Barr virus sequences in Hodgkin’s disease by the polymerase chain reaction. Am J Pathol 139: 393, 1991
Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF, Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin’s disease. Int J Cancer 46: 801 1990
Zur Hausen H, Biochemical approaches to detection of Epstein-Barr virus in human tumors. Cancer Res 36: 678, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herbst, H., Niedobitek, G. Epstein-Barr virus and hodgkin’s disease. Int J Clin Lab Res 23, 13–16 (1993). https://doi.org/10.1007/BF02592274
Issue Date:
DOI: https://doi.org/10.1007/BF02592274